Long‐Term Safety of a Coordinated Delivery Tablet of Enteric‐Coated Aspirin 325 mg and Immediate‐Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk

INTRODUCTION: In two, 6‐month, randomized, double‐blind Phase 3 trials, PA32540 (enteric‐coated aspirin 325 mg and immediate‐release omeprazole 40 mg) compared to aspirin alone was associated with fewer endoscopic gastric and duodenal ulcers in patients requiring aspirin therapy for secondary cardio...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, Jay L., Whellan, David J., Scheiman, James M., Cryer, Byron L., Eisen, Glenn M., Lanas, Angel, Fort, John G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069577/
https://www.ncbi.nlm.nih.gov/pubmed/26725920
http://dx.doi.org/10.1111/1755-5922.12172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069577/
https://www.ncbi.nlm.nih.gov/pubmed/26725920
http://dx.doi.org/10.1111/1755-5922.12172

Ejemplares similares